Z-1217-2017 Class III Terminated
FDA device recall Z-1217-2017 was initiated by Siemens Healthcare Diagnostics, Inc. on May 5, 2016 and is designated Class III. Reason for recall: Complaints of positive shift of patient and QC results when the ALTI assay is calibrated with the Dimension Enzyme II calibrator. Internal investigation has confirmed that patient samples and QC… The recall status is terminated (terminated Feb 2, 2018). Affected quantity: 24,940.00.
Recall details
- Product Type
- Devices
- Report Date
- Feb 22, 2017
- Initiation Date
- May 5, 2016
- Termination Date
- Feb 2, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 24,940.00
Product description
The Enzyme II Calibrator is an in vitro diagnostic product for the Alanine Aminotransferase (ALTI) on the Dimension¿ clinical chemistry system. For prescription use only.
Reason for recall
Complaints of positive shift of patient and QC results when the ALTI assay is calibrated with the Dimension Enzyme II calibrator. Internal investigation has confirmed that patient samples and QC material demonstrate a shift of up to 10% in comparison to results obtained using earlier calibrator lots.
Distribution pattern
Distributed throughout the United States
Code information
Product Lot: 4MD047, 5CD052, 5FD017, 5GD050, 5HD010, 5JD069, 5LD051, 6AD054
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1217-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026